Externally-used health-care drug for treating urticaria

Abstract

The invention provides an externally-used health-care drug for treating urticaria. The drug is prepared from, by weight, 15%-25% of roots of redsepal eveningprimrose, 10%-20% of safflower, 5%-20% of folium artemisiae argyi, 10%-20% of herba menthae, 10%-20% of herba schizonepetae and 10%-20% of radix saposhnikoviae. The drug has the effects of promoting circulation of qi and blood, relieving exterior syndromes by diaphoresis, promoting blood circulation to remove blood stasis, dispelling wind and eliminating dampness.

Description

technical field [0001] The invention belongs to medicines, in particular to an external health-care medicine for treating urticaria. Background technique [0002] Urticaria is commonly called as wheal rash. It is a localized edema reaction due to the dilation and increased permeability of small blood vessels in the skin and mucosa. It usually subsides within 2 to 24 hours, but new rashes occur repeatedly. The course of disease protracted for several days to several months. The etiology of urticaria is very complex, common causes mainly include: food and food additives; inhalation; infection; drugs; physical factors such as mechanical stimulation, heat and cold, sunlight, etc.; insect bites; mental factors and endocrine changes; genetic factors, etc. The basic damage is wheal on the skin. Often have skin pruritus first, then wheal occurs, and is bright red or pale, skin color, and a few patients have edematous erythema. The size and shape of the wheal vary, and the outbre...

AI Technical Summary

Problems solved by technology

For those who often relapse, it is not easy to cure, and the application of western medicine will also produce some side effects